RAET1E-AS1: A Potential Drug Target and Biomarker (G100652739)

Target Name: RAET1E-AS1

NCBI ID: G100652739

RAET1E-AS1

Other Name(s): RAET1E antisense RNA 1, transcript variant 1 | RAET1E antisense RNA 1 | RAET1G-AS1 | RAET1E-AS1 variant 1

RAET1E-AS1: A Potential Drug Target and Biomarker

RAET1E-AS1 is a gene that has garnered significant attention in the scientific community due to its involvement in the regulation of essential cellular processes. The gene has been identified as a potential drug target and biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In this article, we will provide an overview of RAET1E-AS1, its potential drug target status, and its potential as a biomarker for disease.

Potential Drug Target

RAET1E-AS1 is a non-coding RNA molecule that is expressed in various cell types of the body. The molecule has been shown to play a role in the regulation of apoptosis, which is a natural cell death mechanism that helps maintain tissue homeostasis and removes damaged or dysfunctional cells.

Studies have shown that RAET1E-AS1 is highly expressed in cancer cells and is involved in the regulation of cell survival and apoptosis. Additionally, the molecule has been shown to play a role in the regulation of inflammation, which is a critical immune response that helps maintain tissue health.

Given its involvement in these processes, RAET1E-AS1 has potential as a drug target for cancer and neurodegenerative diseases. Targeting this molecule may provide new insights into the mechanisms of these diseases and may lead to the development of new treatments.

Biomarker

RAET1E-AS1 has also been identified as a potential biomarker for several diseases. The molecule has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. Additionally, the molecule has been shown to be involved in the regulation of cell apoptosis, which is a critical event in the development and progression of many diseases.

The potential use of RAET1E-AS1 as a biomarker for disease has implications for the early detection and treatment of these diseases. By identifying individuals who are carrying the RAET1E-AS1 gene, doctors may be able to monitor the development of disease and intervene early, potentially leading to a more effective treatment outcome.

Conclusion

RAET1E-AS1 is a gene that has the potential to be a drug target and biomarker for several diseases. Its involvement in the regulation of apoptosis and inflammation makes it an attractive target for the development of new treatments for cancer and neurodegenerative diseases. As further research is conducted, the potential benefits of RAET1E-AS1 as a drug and biomarker will continue to grow.

Protein Name: RAET1E Antisense RNA 1

The "RAET1E-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAET1E-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets